Microcap drug developer Hemispherx BioPharma (HEB +16.4%) pops after being granted an extension...

|About: Hemispherx Biopharma, Inc (HEB)|By:, SA News Editor

Microcap drug developer Hemispherx BioPharma (HEB +16.4%) pops after being granted an extension by the FDA for its pending New Drug Application for Ampligen, a treatment for Chronic Fatigue Syndrome.